Halobet F
cream
Dose Type
Maruti Pharma Pvt. Ltd.
Manufactured By
Information
Halobet F is the combination of halobetasol propionate (corticosteroid) and fusidic acid (antibiotics). It is used for the treatment of infected dermatoses.
Therapeutic Class
- Halobetasol propionate 0.05%w/w (Corticosteroids)
- Fusidic acid 2%w/w (Antibiotics)
Dose and Direction of Use
- Clean the affected area and hands by clean water.
- Let it dry and apply the medicine gently in the affected area.
- Wash your hands but donot wash the affected area.
Mode of Action
Halobeasol works by activating natural substances in the skin to reduce swelling, redness, and itching.Fusidic acid helps prevent bacterial growth while the immune system clears the infection. Fusidic acid works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome.
Uses
- Treatment of infected dermatoses
Contraindications
- Hypersensitivity to any ingredients of the product
Precautions and Warning
- Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression with the potential for glucocorticosteroid insufficiency after withdrawal of treatment. Manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria can also be produced in some patients by systemic absorption of topical corticosteroids while on treatment.
- Patients applying a topical steroid to a large surface area or to areas under occlusion should be evaluated periodically for evidence of HPA axis suppression.
- If irritation develops, HALOBET-F Cream should be discontinued and appropriate therapy instituted.
- Patients with evidence of pre-existing skin atrophy are prone to exacerbation.
- Patients with glaucoma or cataracts can have potential worsening if sufficient absorption of Halobetasol Propionate occurs.
- Avoid occlusive dressings or use over large surface areas.
- Face, groin & axillae are more susceptible to adverse topical effects.
- Halobetasol Propionate may increase the risk of serious or fatal infection in individuals exposed to viral diseases such as chickenpox or measles.